Loading…

P1389: RUXOLITINIB DEMONSTRATES A GREATER CORTICOSTEROID‐SPARING EFFECT THAN BEST AVAILABLE THERAPY IN PATIENTS WITH CORTICOSTEROID‐REFRACTORY/DEPENDENT CHRONIC GRAFT‐VS‐HOST DISEASE

Saved in:

Bibliographic Details
Published in:	HemaSphere 2022-06, Vol.6 (Suppl), p.1273-1274
Main Authors:	Zeiser, R., Russo, D., Ram, R., Hashmi, S., Chakraverty, R., Moritz Middeke, J., Giebel, S., Sarkar, R., Gowda, M., Gunes, S., Stefanelli, T., Lee, S. J., Teshima, T., Locatelli, F.
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!